Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Fiona Pearce"'
Publikováno v:
Journal of Ophthalmic Inflammation and Infection, Vol 14, Iss 1, Pp 1-5 (2024)
Abstract Purpose To report a case of endogenous Lomentospora prolificans endophthalmitis treated with the novel antifungal agent Olorofim. Case report A 57-year-old man developed disseminated Lomentospora prolificans with right endophthalmitis on the
Externí odkaz:
https://doaj.org/article/f52c594b3c444dc1a0350ce6745ec063
Autor:
Sarin Kc, Lydia Wenxin Lin, Diana Beatriz Samson Bayani, Yaroslava Zemlyanska, Amanda Adler, Jeonghoon Ahn, Kelvin Chan, Dechen Choiphel, Anne Julienne Genuino-Marfori, Brendon Kearney, Yuehua Liu, Ryota Nakamura, Fiona Pearce, Shankar Prinja, Raoh-Fang Pwu, Arsul Akmal Shafie, Binyan Sui, Auliya Suwantika, Sean Tunis, Hui-Min Wu, John Zalcberg, Kun Zhao, Wanrudee Isaranuwatchai, Yot Teerawattananon, Hwee-Lin Wee
Publikováno v:
International Journal of Health Policy and Management, Vol 12, Iss Issue 1, Pp 1-9 (2023)
Background Globally, there is increasing interest in the use of real-world data (RWD) and real-world evidence (RWE) to inform health technology assessment (HTA) and reimbursement decision-making. Using current practices and case studies shared by ele
Externí odkaz:
https://doaj.org/article/7bf76eeeb90a4384ada35dd44a3e795a
Autor:
Manushi Sharma, Yot Teerawattananon, Saudamini Vishwanath Dabak, Wanrudee Isaranuwatchai, Fiona Pearce, Songyot Pilasant, Junainah Sabirin, Mayfong Mayxay, Melissa Guerrero, Nguyen Khanh Phuong, Sudigdo Sastroasmoro, Thant Sin Htoo
Publikováno v:
Health Research Policy and Systems, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background Progress towards achieving Universal Health Coverage and institutionalizing healthcare priority setting through health technology assessment (HTA) in the Association of South-East Asian Nations (ASEAN) region varies considerably a
Externí odkaz:
https://doaj.org/article/ac42eab2d4ee45788666ba4be004eaf7
Autor:
Pramudi Wijayasiri, Jatinder Hayre, Edward S. Nicholson, Philip Kaye, Emilie A. Wilkes, Jonathan Evans, Guruprasad P. Aithal, Gabriela Jones, Fiona Pearce, Aloysious D. Aravinthan
Publikováno v:
JHEP Reports, Vol 3, Iss 5, Pp 100329- (2021)
Background & Aims: The clinical prevalence of Wilson’s disease (WD) in the UK remains unknown. The estimated genetic prevalence in the UK, 142/million, is higher than the clinical prevalence (15/million) reported in other European studies. The aim
Externí odkaz:
https://doaj.org/article/aecd8f2dc20f47caa0624e5e6d4f7dcb
Autor:
Ping-Tee Tan, Mohamed Ismail Abdul Aziz, Fiona Pearce, Wan-Teck Lim, David Bin-Chia Wu, Kwong Ng
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Non-small-cell lung cancer (NSCLC) accounts for 85% of all lung cancers and is associated with a poor prognosis. Afatinib is an irreversible ErbB family blocker recommended in clinical guidelines as a first-line treatment for NSCL
Externí odkaz:
https://doaj.org/article/a648f17157914f9e908b6b4c5c736c8c
Publikováno v:
Rheumatology. 61:SI107-SI109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9cff2d5a4a96c49a599daa4688a5f12
https://doi.org/10.1093/rheumatology/keac193
https://doi.org/10.1093/rheumatology/keac193
Autor:
Kwong Ng, Fiona Pearce, Horace C.W. Choi, Cameron Hall, Mohamed Ismail Abdul Aziz, Lee Cheng Phua, Jeffrey Low, Joseph T. Wu, Mark Jit
Publikováno v:
Vaccine. 39:2255-2263
Background The nonavalent human papillomavirus (HPV) vaccine has been shown to extend protection against oncogenic HPV types 31/33/45/52/58 (HPV-OV) not covered by the bivalent and quadrivalent HPV vaccines. Besides its clinical benefit, evidence on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3285e868685474b62a018f829f45461e
https://doi.org/10.1016/j.vaccine.2021.03.040
https://doi.org/10.1016/j.vaccine.2021.03.040
Autor:
Mohamed Ismail Abdul Aziz, Joanne Ngeow, Swee Sung Soon, Grace Wong, Yongqiang Tan, Fiona Pearce, Wen-Yee Chay, Kwong Ng, Li-Jen Cheng
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 21:441-448
Objectives: To determine whether olaparib maintenance therapy, used with and without restriction by BRCA1/2 mutation status, is cost-effective at the population level for platinum-sensitive relapsed ovarian cancer in Singapore.Methods: A partitioned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0b0518deafc9c667731b5bef4213774
https://doi.org/10.1080/14737167.2021.1890587
https://doi.org/10.1080/14737167.2021.1890587
Autor:
Lydia Loke, Fiona Pearce, Li-Jen Cheng, Elaine Hsuen Lim, Mohamed Ismail Abdul Aziz, Kwong Ng
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 21:449-456
This study evaluates the cost-effectiveness of pertuzumab with trastuzumab biosimilar and docetaxel as initial treatment for HER2-positive metastatic breast cancer (MBC) in Singapore.A partitioned survival model with three health states was developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da8de86d72e4b29cde3c5cbfdf4f229
https://doi.org/10.1080/14737167.2021.1880323
https://doi.org/10.1080/14737167.2021.1880323
Autor:
Myron Odingo, Megan Rutter, Peter Lanyon, Matthew Grainge, David Groves, Mary Bythell, Jeanette Aston, Sarah Stevens, Fiona Pearce
Publikováno v:
Rheumatology. 61
Background/Aims People with ANCA-associated vasculitis (AAV) have high rates of hospital admissions. They may have emergency admissions at the time of diagnosis, or day case admissions to receive immunosuppressive treatment. We describe the trends in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::302c8cba13198bf2cfd3d7b4f5628adc
https://doi.org/10.1093/rheumatology/keac133.301
https://doi.org/10.1093/rheumatology/keac133.301